Gefitinib: A Breakthrough in Targeted Cancer Thera..

إنشاء مقالة جديدة

4 ث

Gefitinib: A Breakthrough in Targeted Cancer Therapy | #gefitinib India manufacturers

Gefitinib: A Breakthrough in Targeted Cancer Therapy

Gefitinib: A Breakthrough in Targeted Cancer Therapy

Gefitinib is an epidermal growth factor receptor (EGFR) inhibitor that belongs to the class of tyrosine kinase inhibitors (TKIs). It specifically targets cancer cells that exhibit mutations in the EGFR gene,

إعجاب

علق

شارك